annual cash & cash equivalents:
$387.88M-$9.57M(-2.41%)Summary
- As of today (July 3, 2025), PCVX annual cash & cash equivalents is $387.88 million, with the most recent change of -$9.57 million (-2.41%) on December 31, 2024.
- During the last 3 years, PCVX annual cash & cash equivalents has risen by +$318.89 million (+462.26%).
- PCVX annual cash & cash equivalents is now -53.53% below its all-time high of $834.66 million, reached on December 31, 2022.
Performance
PCVX Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$346.85M-$41.03M(-10.58%)Summary
- As of today (July 3, 2025), PCVX quarterly cash & cash equivalents is $346.85 million, with the most recent change of -$41.03 million (-10.58%) on March 31, 2025.
- Over the past year, PCVX quarterly cash & cash equivalents has dropped by -$264.66 million (-43.28%).
- PCVX quarterly cash & cash equivalents is now -66.97% below its all-time high of $1.05 billion, reached on September 30, 2024.
Performance
PCVX quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
PCVX Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.4% | -43.3% |
| 3 y3 years | +462.3% | +71.9% |
| 5 y5 years | +557.7% | +124.1% |
PCVX Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -53.5% | +462.3% | -67.0% | +45.6% |
| 5 y | 5-year | -53.5% | +557.7% | -67.0% | +402.8% |
| alltime | all time | -53.5% | +557.7% | -67.0% | +488.1% |
PCVX Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $346.85M(-10.6%) |
| Dec 2024 | $387.88M(-2.4%) | $387.88M(-63.1%) |
| Sep 2024 | - | $1.05B(+102.5%) |
| Jun 2024 | - | $518.67M(-15.2%) |
| Mar 2024 | - | $611.51M(+53.9%) |
| Dec 2023 | $397.45M(-52.4%) | $397.45M(-27.1%) |
| Sep 2023 | - | $545.13M(+2.7%) |
| Jun 2023 | - | $531.03M(+39.6%) |
| Mar 2023 | - | $380.45M(-54.4%) |
| Dec 2022 | $834.66M | $834.66M(+199.8%) |
| Sep 2022 | - | $278.40M(+16.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $238.17M(+18.1%) |
| Mar 2022 | - | $201.74M(+192.4%) |
| Dec 2021 | $68.98M(-82.1%) | $68.98M(-38.4%) |
| Sep 2021 | - | $112.04M(-25.8%) |
| Jun 2021 | - | $151.00M(-24.1%) |
| Mar 2021 | - | $198.94M(-48.5%) |
| Dec 2020 | $386.20M(+554.8%) | $386.20M(-2.7%) |
| Sep 2020 | - | $397.05M(-3.2%) |
| Jun 2020 | - | $410.05M(+164.9%) |
| Mar 2020 | - | $154.79M(+162.5%) |
| Dec 2019 | $58.98M(-10.8%) | $58.98M |
| Dec 2018 | $66.09M | - |
FAQ
- What is Vaxcyte annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Vaxcyte?
- What is Vaxcyte annual cash & cash equivalents year-on-year change?
- What is Vaxcyte quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Vaxcyte?
- What is Vaxcyte quarterly cash & cash equivalents year-on-year change?
What is Vaxcyte annual cash & cash equivalents?
The current annual cash & cash equivalents of PCVX is $387.88M
What is the all time high annual cash & cash equivalents for Vaxcyte?
Vaxcyte all-time high annual cash & cash equivalents is $834.66M
What is Vaxcyte annual cash & cash equivalents year-on-year change?
Over the past year, PCVX annual cash & cash equivalents has changed by -$9.57M (-2.41%)
What is Vaxcyte quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of PCVX is $346.85M
What is the all time high quarterly cash & cash equivalents for Vaxcyte?
Vaxcyte all-time high quarterly cash & cash equivalents is $1.05B
What is Vaxcyte quarterly cash & cash equivalents year-on-year change?
Over the past year, PCVX quarterly cash & cash equivalents has changed by -$264.66M (-43.28%)